Cornerstone Capital Management Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,600	Closed	-$84K	–	1413
2016 Q2	$84K	Sell	3,600 -15,931	-82%	-$514K	﹤0.01%	1283
2016 Q1	$791K	Sell	19,531 -6,850	-26%	-$278K	0.01%	953
2015 Q4	$1.63M	Sell	26,381 -15,067	-36%	-$813K	0.01%	789
2015 Q3	$1.68M	Buy	+41,448	New	+$2.15M	0.02%	767
2015 Q2	–	Sell	-19,900	Closed	-$1.27M	–	1446
2015 Q1	$1.27M	Buy	19,900 +1,000	+5%	+$67.8K	0.01%	837
2014 Q4	$1.17M	Buy	18,900 +1,900	+11%	+$93.8K	0.01%	851
2014 Q3	$660K	Buy	+17,000	New	+$602K	0.01%	935

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cornerstone Capital Management Holdings's IONS Position: Q3 2016 in Review

Cornerstone Capital Management Holdings sold out of Ionis Pharmaceuticals (IONS) in Q3 2016, closing a stake of 3,600 shares — an estimated $84K sold.

Cornerstone Capital Management Holdings first reported a position in IONS in Q3 2014 and held it in 7 quarters. The position peaked at $1.68M in Q3 2015. 281 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

Cornerstone Capital Management Holdings reported no remaining Ionis Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 3,600 Ionis Pharmaceuticals shares in Q3 2016, an estimated $84K.
Cornerstone Capital Management Holdings first reported a position in Ionis Pharmaceuticals in Q3 2014 and held it in 7 quarters.
Cornerstone Capital Management Holdings's Ionis Pharmaceuticals position peaked at $1.68M in Q3 2015.
281 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q3 2016, filed 16 Nov 2016.